AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LITHIUM CARBONATE
6 registrations across 4 African markets— 3 active
Markets with LITHIUM CARBONATE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LITHOSUN SR Tablet | 🇰🇪Kenya | SUN PHARMACEUTICAL INDUSTRIES LTD | active | Jan 2030 |
| LITHIUM CARBONATE TABLET; ORAL | 🇿🇼Zimbabwe | CAPS PVT LTD | active | Dec 2027 |
| NITROLITH 500 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| NITROLITH 250 mg | 🇿🇦South Africa | Adcock Ingram Limited | suspended | May 2025 |
| TERALITHE Comprimé sécable / 250 MG | 🇹🇳Tunisia | LABORATOIRES DELBERT | expired | Jan 2023 |
| CAMCOLIT 400 | 🇿🇦South Africa | Pharmacare Limited û Woodmead | active | Jan 1900 |
LITHIUM CARBONATE in Africa — Regulatory Overview
LITHIUM CARBONATE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Kenya, Tunisia, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 3 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.